# Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS

> **NCT02106637** · NA · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Smoking Cessation

## Interventions

- **DRUG:** Varenicline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02106637
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2018-08
- **Final completion:** 2018-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-12-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02106637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02106637, "Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02106637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*